https://www.selleckchem.com/pr....oducts/pf-4708671.ht
etric properties, and its sensitivity to detect symptom changes after treatment ensure NSS-P future use in clinical and research settings. We validated a brief instrument to assess NT1 symptom frequency, severity and consequences in ≥10-year-old children and adolescents, with four clinically relevant severity score ranges. This scale constitutes a relevant tool to improve and provide guidance for NT1 management in pediatric populations. The ease of administration, its good psychometric properties, and its sensitivity to detect sympto
Curtir
Comentario
Compartilhar
